Skip to content

Addiction research published in 2018

48 studies whose primary subject is addiction were published in 2018, up from 41 in 2017. Newest first. Back to the addiction overview

Studies

Treatment effectiveness of a mindfulness-based inpatient group psychotherapy in adolescent substance use disorder - study protocol for a randomized controlled trial.

Trials December 27, 2018 Christiane Baldus, Laura Mokros, Anne Daubmann et al.

Background: Current treatments for adolescents with substance use disorder (SUD) have had only limited success. In recent years, research has underlined the role of self-regulatory processes and impulsivity in the development and maintenance of SUD in adolescents. Mindfulness has gained much attention due to its capacity to influence self-regulatory processes, particularly in adult populations....

Hallucinogen Persisting Perception Disorder After Ibogaine Treatment for Opioid Dependence.

Journal of Clinical Psychopharmacology December 1, 2018 Thomas Knuijver, Maarten Belgers, Wiebren Markus et al.

expressed in brain regions associated with emotional processing. Modulation of the hypothalamic-pituitary-adrenal axis by altering cortisol tone also seems to be involved in this effect. The ECS modulates stress and anxiety. Serum AEA and 2-AG levels are increased after stress, and AEA levels are negatively associated to baseline anxiety and are significantly reduced in womenwith major...

Evaluating the abuse potential of psychedelic drugs as part of the safety pharmacology assessment for medical use in humans.

Neuropharmacology November 2018 David J Heal, Jane Gosden, Sharon L. Smith

Psychedelics comprise drugs come from various pharmacological classes including 5-HT2A agonists, indirect 5-HT agonists, e.g., MDMA, NMDA antagonists and κ-opioid receptor agonists. There is resurgence in developing psychedelics to treat psychiatric disorders with high unmet clinical need. Many, but not all, psychedelics are schedule 1 controlled drugs (CDs), i.e., no approved medical use. For...

Ketamine for the treatment of addiction: Evidence and potential mechanisms.

Neuropharmacology November 2018 I Ivan Ezquerra-Romano, W Lawn, E Krupitsky et al.

Ketamine is a dissociative anaesthetic drug which acts on the central nervous system chiefly through antagonism of the n-methyl-d-aspartate (NMDA) receptor. Recently, ketamine has attracted attention as a rapid-acting anti-depressant but other studies have also reported its efficacy in reducing problematic alcohol and drug use. This review explores the preclinical and clinical research into...

A sub-set of psychoactive effects may be critical to the behavioral impact of ketamine on cocaine use disorder: Results from a randomized, controlled laboratory study.

Neuropharmacology November 1, 2018 Elias Dakwar, Edward V. Nunes, Carl L. Hart et al. 83 citations

Efforts to translate sub-anesthetic ketamine infusions into widespread clinical use have centered around developing medications with comparable neurobiological activity, but with attenuated psychoactive effects so as to minimize the risk of behavioral toxicity and abuse liability. Converging lines of research, however, suggest that some of the psychoactive effects of sub-anesthetic ketamine may...

Why MDMA therapy for alcohol use disorder? And why now?

Neuropharmacology November 1, 2018 Ben Sessa 61 citations

Alcohol use disorder represents a serious clinical, social and personal burden on its sufferers and a significant financial strain on society. Current treatments, both psychological and pharmacological are poor, with high rates of relapse after medical detoxification and dedicated treatment programs. The earliest historical roots of psychedelic drug-assisted psychotherapy in the 1950s were...

The neuropsychopharmacology of cannabis: A review of human imaging studies

Pharmacology & Therapeutics October 20, 2018 Michael Bloomfield, Chandni Hindocha, Sebastian F Green et al. 236 citations

receptor. Acutely, cannabis and THC produce a range of effects on several neurocognitive and pharmacological systems. These include effects on executive, emotional, reward and memory processing via direct interactions with the endocannabinoid system and indirect effects on the glutamatergic, GABAergic and dopaminergic systems. Cannabidiol, a non-intoxicating cannabinoid found in some forms of...

Kappa Opioid Receptor Agonist Mesyl Sal B Attenuates Behavioral Sensitization to Cocaine with Fewer Aversive Side-Effects than Salvinorin A in Rodents.

Molecules October 11, 2018 Bronwyn M Kivell, Kelly F Paton, Nitin Kumar et al. 45 citations

The acute activation of kappa opioid receptors (KOPr) produces antinociceptive and anti-cocaine effects, however, their side-effects have limited further clinical development. Mesyl Sal B is a potent and selective KOPr analogue of Salvinorin A (Sal A), a psychoactive natural product isolated from the plant Salvia divinorum. We assessed the antinociceptive, anti-cocaine, and side-effects of...

Increased use of illicit drugs in a Dutch cluster headache population

Cephalalgia October 5, 2018 Ilse F. de Coo, Willemijn C. Naber, Leopoldine A. Wilbrink et al. 47 citations

Introduction Many patients with cluster headache report use of illicit drugs. We systematically assessed the use of illicit drugs and their effects in a well-defined Dutch cluster headache population. Methods In this cross-sectional explorative study, 756 people with cluster headache received a questionnaire on lifetime use and perceived effects of illicit drugs. Results were compared with age...

Highway to hell or magic smoke? The dose-dependence of Δ9-THC in place conditioning paradigms.

Learning & Memory September 2018 Rimas A Kubilius, Paul M Kaplick, Carsten T. Wotjak preprint

The prerequisites for responsible cannabis use are at the heart of current inquiries into cannabis decriminalization by policy makers as well as academic and nonacademic stakeholders at a global scale. Δ9-tetrahydrocannabinol (Δ9-THC), the prime psychoactive compound of the cannabis sativa, as well as cannabimimetics that resemble the pharmacological properties and psychological effects of...

Shamanism: Addiction and Soul Sickness

Oxford Medicine Online September 1, 2018 Dean Taraborelli, Alberto Villoldo, G. Muñoz

The path of healing, self-discovery, and tackling the existential questions as to why people use drugs is addressed in this chapter. The chapter outlines the healing concepts within the Quero tradition, as these peoples were direct descendants of the Inca from ancient Andean Peru. The cosmology and oral traditions through healing motifs are timeless irrespective of cultural and chronological...

Therapeutic Potential Ascribed to Ayahuasca by Users in the Czech Republic

Journal of Psychoactive Drugs August 30, 2018 Miroslav Horák, Lea Hasíková, Nahanga Verter 16 citations

This article focuses on the therapeutic potential ascribed to ayahuasca by users in the Czech Republic. Following an online survey, the fieldwork among users of ayahuasca was carried out from November 2015 to December 2016. The research sample consisted of 46 persons (23 women and 23 men), who took part at least once in some type of ayahuasca ritual and/or were the facilitators of the ayahuasca...

Psychedelics as anti-inflammatory agents

International Review of Psychiatry July 4, 2018 Thomas W. Flanagan, Charles D. Nichols 263 citations

Serotonin (5-hydroxytryptamine, 5-HT)2A receptor agonists have recently emerged as promising new treatment options for a variety of disorders. The recent success of these agonists, also known as psychedelics, like psilocybin for the treatment of anxiety, depression, obsessive-compulsive disorder (OCD), and addiction, has ushered in a renaissance in the way these compounds are perceived in the...

Plant based assisted therapy for the treatment of substance use disorders - part 1. The case of takiwasi center and other similar experiences

Cultura y Droga July 3, 2018 Matteo Politi, Fabio Friso, Jacques Mabit 19 citations

Objective. This article aims to give an overview of the major American centers using traditional herbal medicine or their derivatives in the treatment of substance dependence. Methodology. For the purpose of this article we have considered a small number of plants hailing from South, Central and North America. The research has been based on scientific literature, information exchange with...

DOI: 10.17151/culdr.2018.23.26.6 (opens in new tab) Substance use Coca Traditional medicine Alternative medicine +3

Mindfulness-based relapse prevention combined with virtual reality cue exposure for methamphetamine use disorder: Study protocol for a randomized controlled trial.

Contemporary Clinical Trials July 2018 Xi Jing Chen, Dong Mei Wang, Li Dan Zhou et al.

Mindfulness-based relapse prevention (MBRP) is a method that combines cognitive behavioral relapse prevention with mindfulness practice. Research suggests that MBRP can effectively reduce withdrawal/craving in people with substance use disorder (SUD). An important part of MBRP is to practice mindfulness meditation to cope with high-risk situations for relapse, such as stimuli and situations...

DOI: 10.1016/j.cct.2018.04.006 (opens in new tab) Full text (opens in new tab) Substance use disorder Cue exposure Methamphetamine addiction Randomized controlled trial +1

How Organisms Gained Causal Independence and How It Might Be Quantified.

Biology June 29, 2018 Keith Douglas Farnsworth

Two broad features are jointly necessary for autonomous agency: organisational closure and the embodiment of an objective-function providing a ‘goal’: so far only organisms demonstrate both. Organisational closure has been studied (mostly in abstract), especially as cell autopoiesis and the cybernetic principles of autonomy, but the role of an internalised ‘goal’ and how it is instantiated by...

DARK Classics in Chemical Neuroscience: Psilocybin

ACS Chemical Neuroscience June 29, 2018 Haden A. Geiger, Madeline G. Wurst, R. Nathan Daniels 139 citations

Psilocybin is found in a family of mushrooms commonly known as "magic mushrooms" that have been used throughout history to induce hallucinations. In the late 1950s Albert Hofmann, of Sandoz Laboratories, identified and synthesized the psychoactive compounds psilocybin and psilocin which are found in psilocybe mushrooms. Psilocybin was marketed by Sandoz as Indocybin for basic...

DOI: 10.1021/acschemneuro.8b00186 (opens in new tab) Psilocybin Hallucinogen Alcohol addiction Pharmacology

Psychedelic therapy for smoking cessation: Qualitative analysis of participant accounts

Journal of Psychopharmacology June 25, 2018 Tehseen Noorani, Albert Garcia‐romeu, Thomas Cody Swift et al. 285 citations

Background: Recent pilot trials suggest feasibility and potential efficacy of psychedelic-facilitated addiction treatment interventions. Fifteen participants completed a psilocybin-facilitated smoking cessation pilot study between 2009 and 2015. Aims: The aims of this study were as follows: (1) to identify perceived mechanisms of change leading to smoking cessation in the pilot study; (2) to...

DOI: 10.1177/0269881118780612 (opens in new tab) Addiction Psilocybin Qualitative research Smoking cessation +7

Ontological addiction theory: Attachment to me, mine, and I.

Journal of Behavioral Addictions June 7, 2018 William van Gordon, Edo Shonin, Sofiane Diouri et al.

Background: Ontological addiction theory (OAT) is a novel metaphysical model of psychopathology and posits that human beings are prone to forming implausible beliefs concerning the way they think they exist, and that these beliefs can become addictive leading to functional impairments and mental illness. The theoretical underpinnings of OAT derive from the Buddhist philosophical perspective...

A phenomenological investigation into the lived experience of ibogaine and its potential to treat opioid use disorders

Journal of Psychedelic Studies June 1, 2018 Thaddeus James Camlin, Donald Eulert, A. Thomas Horvath et al. 21 citations

This study examined the lived experience of individuals who underwent ibogaine treatment for an opioid use disorder. Semi-structured interview questions probed for potential changes in predetermined categories derived from a literature review. Participants' experiences with ibogaine were analyzed for commonalities and emergent themes. Categories that emerged revealed themes about subjective...